Artivion (AORT) vs Beta Bionics (BBNX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Beta Bionics (BBNX) has outperformed Artivion (AORT) over the past year, losing 18.4% versus a loss of 46.7%. Artivion is the larger company by market cap ($1.05 billion vs $975.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AORT | BBNX |
|---|---|---|
| Share price | $21.61 | $18.08 |
| Market cap | $1.05B | $975.35M |
| 1-day change | -1.05% | -2.95% |
| YTD return | -52.62% | -40.66% |
| 1-year return | -46.66% | -18.37% |
| 5-year return | +1.17% | — |
| Forward P/E | 28.88 | — |
| EPS (TTM) | $-0.07 | $-1.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $48.25 | $32.71 |
| 52-week low | $19.16 | $8.80 |
| Distance from 52-week high | -55.21% | -44.73% |
| Analyst consensus | none | buy |
| Avg. price target upside | +95.05% | +31.64% |
| Average volume | 639.01K | 1.29M |
| Shares outstanding | 48.76M | 53.95M |
| Employees | 1,800 | 420 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BBNX has outperformed AORT by 28.3 percentage points over the past year.
About Artivion
AORT stock →Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.
Healthcare · Medical Devices · 1,800 employees
About Beta Bionics
BBNX stock →Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older.
Healthcare · Medical Devices · 420 employees
AORT vs BBNX FAQ
Which is bigger, Artivion or Beta Bionics?
Artivion (AORT) is larger, with a market capitalization of $1.05B compared with $975.35M for Beta Bionics (BBNX).
Which stock has performed better over the past year, AORT or BBNX?
BBNX returned -18.37% over the past 12 months, compared with -46.66% for AORT (price return, excluding dividends). Past performance does not predict future results.
Are Artivion and Beta Bionics in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.